Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Merck
Company Monitoring Page for Merck
latest headlines for company on cafepharma
Merck discontinues some cancer drug development with China's Sichuan Kelun
Reuters
Tue, 10/24/23 - 10:00 am
Tags:
Merck
,
Sichuan Kelun Pharmaceutical
,
cancer
,
oncology
Merck, BMS Score Separate Late-Stage Victories in Bladder Cancer at ESMO
BioSpace
Mon, 10/23/23 - 05:15 pm
Tags:
ESMO
,
Merck
,
Bristol Myers Squibb
,
bladder cancer
,
PD-1 inhibitors
,
Keytruda
,
Padcev
,
Opdivo
Merck's early KRAS data suggest combination-friendly safety
Fierce Biotech
Mon, 10/23/23 - 10:30 am
Tags:
Merck
,
ESMO
,
KRAS inhibitors
,
Amgen
,
Lumakras
ESMO: AstraZeneca proposes adding Lynparza to Imfinzi as endometrial cancer race heats up
Fierce Pharma
Mon, 10/23/23 - 09:07 am
Tags:
ESMO
,
AstraZeneca
,
Merck
,
Lynparza
,
endometrial cancer
ESMO: Bristol Myers' Opdivo chalks up bladder cancer win. But a rival combo casts long shadow
Fierce Pharma
Sun, 10/22/23 - 06:06 pm
Tags:
ESMO
,
Bristol Myers Squibb
,
Opdivo
,
bladder cancer
,
Padcev
,
Keytruda
,
Merck
ESMO: In PD-1 battle GSK waged on Merck, Jemperli appears to show survival edge over Keytruda in lung cancer
Fierce Pharma
Fri, 10/20/23 - 11:47 am
Tags:
Merck
,
GSK
,
Keytruda
,
Jemperli
,
ESMO
,
nonsquamous non-small cell lung cancer
Merck pays $4B upfront for rights to 3 Daiichi ADCs in huge bet on post-Keytruda future
Fierce Biotech
Fri, 10/20/23 - 09:55 am
Tags:
Merck
,
Daiichi Sankyo
,
AstraZeneca
,
antibody-drug conjugate
ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer
Fierce Pharma
Wed, 10/18/23 - 11:38 am
Tags:
Seagen
,
Astellas
,
Merck
,
Padcev
,
Keytruda
,
bladder cancer
,
ESMO
Merck Pushes Keytruda into Perioperative NSCLC Setting with FDA Approval
BioSpace
Tue, 10/17/23 - 09:36 pm
Tags:
Merck
,
Keytruda
,
non-small cell lung cancer
Merck's Keytruda hits overall survival goal in early lung cancer as FDA decision nears
Fierce Pharma
Tue, 10/10/23 - 10:18 am
Tags:
Merck
,
Keytruda
,
non-small cell lung cancer
Eikon cuts staff 'to become more efficient,' letter from CEO Perlmutter reveals
Fierce Biotech
Sun, 10/8/23 - 02:44 pm
Tags:
Eikon Therapeutics
,
Roger Perlmutter
,
Merck
,
layoffs
Merck eyes new bladder cancer space with positive Keytruda trial in muscle-invasive disease
Fierce Pharma
Thu, 10/5/23 - 09:03 pm
Tags:
Merck
,
Keytruda
,
bladder cancer
,
muscle-invasive urothelial carcinoma
US plans shift of Merck COVID treatment to commercial market
Reuters
Thu, 10/5/23 - 10:16 am
Tags:
Merck
,
COVID-19
,
Lagevrio
,
molnupiravir
Sanofi pays Teva $500M to join Merck, Roivant in red-hot bowel disease race
Fierce Biotech
Wed, 10/4/23 - 09:48 am
Tags:
Sanofi
,
Teva Pharmaceutical
,
inflammatory bowl disease
,
IBD
,
Merck
,
Roivant
FDA gives Merck priority review for blood vessel disorder therapy sotatercept
Medical Marketing and Media
Thu, 09/28/23 - 11:42 pm
Tags:
Merck
,
PAH
,
sotatercept
,
FDA
Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo
BioSpace
Fri, 09/22/23 - 11:53 am
Tags:
Merck
,
Seagen
,
Astellas
,
urothelial cancer
,
clinical trials
,
bladder cancer
,
Padcev
,
Keytruda
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Fri, 09/22/23 - 11:46 am
Tags:
Merck
,
Eisai
,
Keytruda
,
Lenvima
,
melanoma
,
colorectal cancer
,
non-small cell lung cancer
Merck (MRK) Keytruda Cervical Cancer sBLA Gets FDA Priority Tag
Yahoo/Zacks.com
Thu, 09/21/23 - 06:32 pm
Tags:
Merck
,
Keytruda
,
FDA
,
cervical cancer
,
priority review
1ST Biotherapeutics and Merck to assess cancer combination treatment
Clinical Trials Arena
Wed, 09/20/23 - 11:09 pm
Tags:
Merck
,
1st Biotherapeutics
,
Keytruda
,
solid tumors
,
clinical trials
HHS argues Merck 'lacks standing' to sue over Medicare price negotiations
Fierce Pharma
Wed, 09/13/23 - 11:38 am
Tags:
Merck
,
Inflation Reduction Act
,
HHS
,
legal
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.